This article was taken from Pharmafile Summer 2022, page 22. Samedan Ltd
Learn more about Aptar Pharma Expertise
in Pulmonary Drug Delivery
This Might Also Be of Interest

Sustainable Propellants and Bioequivalence Innovation in OINDPs
Publications, Pharmaceutical, Market Insights, Product Solutions, Innovation & Insights

Elevating Medication Adherence and Clinical Outcomes with Connected Drug Delivery
Publications, Pharmaceutical, Drug Delivery Innovations, Brand Differentiation, Market Insights, Product Solutions

Advancing Inhaled & Nasal Drug Clinical Studies: Insights & Strategies
Webinars, Pharmaceutical, Market Insights, Product Solutions, Drug Delivery Innovations

Leachables Assessment: New pMDI with Low-GWP Propellants
Publications, Pharmaceutical, Sustainability, Drug Delivery Innovations, Brand Differentiation, Market Insights, Product Solutions